About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Cleveland | 263 Studies

Clinical Trials Prostate CancerCleveland

Prostate Cancer Clinical Trials in Cleveland

Find 263 clinical trials for prostate cancer near Cleveland, Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Cleveland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 263 trials

CompletedPhase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and ChemotherapyThe purpose is to see how quickly two different types of prostate cancer participants respond when taking enzastaurin.NCT00428714·Los Angeles, California and 10 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedSunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyThis study will compare the safety and efficacy of sunitinib in combination with prednisone versus placebo and prednisone in patients that have metastatic castration-resistant…NCT00676650·Decatur, Alabama and 204 others

CompletedA Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone AcetateA 2-part, Phase 1-2, open-label, parallel group, randomized study in patients with Castration-Resistant Prostate Cancer (CRPC) who are no longer responding to treatment with…NCT01685268·Los Angeles, California and 31 others

CompletedA Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid TumorsThis will be a Phase 1, open label, 2-sequence, crossover study to establish the BE of the current commercial formulation (Generation 3.1 talazoparib capsules) to the proposed…NCT04672460·Encinitas, California and 30 others

Active not recruitingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsThis is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of cabozantinib taken in combination with…NCT03170960·Gilbert, Arizona and 123 others

CompletedRadiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerRATIONALE: Radiation therapy (RT) uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002597·Birmingham, Alabama and 238 others

Active not recruitingA Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate CancerThis study is a large, prospective, pragmatic, controlled comparison of patient-centric outcomes \[quality of life (QOL), toxicity, and disease control\] between parallel cohorts…NCT03561220·Birmingham, Alabama and 52 others

TerminatedStereotactic Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.NCT00619515·Cleveland, Ohio and 3 others

CompletedLiposomal Doxorubicin in Treating Patients With Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004014·Cleveland, Ohio

TerminatedImproving Erectile Function and Quality of Life After Prostate Cancer TreatmentThis is a research study of erectile dysfunction (ED) in men diagnosed with prostate cancer. 144 patients and partners will participate in the study.NCT01996852·Cleveland, Ohio

CompletedEribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyThis phase II trial is studying how well eribulin mesylate (E7389; Halichondrin B Analog) works in treating patients with metastatic prostate cancer that did not respond to…NCT00337077·Scottsdale, Arizona and 146 others

CompletedDeveloping Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer SurvivorsProstate cancer is a significant concern for Latiné men, with over 17,000 new cases annually.NCT06435871·Cleveland, Ohio

CompletedLow-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.RATIONALE: Eating a diet low in residue (fiber, fat, and certain milk or vegetable products) may help prevent or reduce diarrhea caused by pelvic radiation therapy.NCT00258401·Cleveland, Ohio

Completed(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate CancerThe purpose of this trial is to study the effect of adjuvant or immediate hormonal therapy, versus placebo, in subjects who have either undergone a primary therapy (principally…NCT00673205·Wooloongabba, Queensland and 127 others

CompletedSafety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001The purpose of this study is to evaluate safety and tolerability of ODM-201 in patients with castrate resistant prostate cancer.NCT01429064·Wheat Ridge, Colorado and 16 others

CompletedS9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate CancerRATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00004124·Anchorage, Alaska and 233 others

Active not recruitingA Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)This study will investigate the maximum tolerated dose, the recommended dose for expansion (RDE), safety, efficacy, and pharmacokinetics of gocatamig alone, gocatamig with…NCT04471727·Los Angeles, California and 10 others

Active not recruitingAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens.NCT01368588·Mobile, Alabama and 477 others

CompletedHormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT00288080·Birmingham, Alabama and 253 others

CompletedEnzalutamide in Patients With High-risk Prostate CancerThe purpose of this study is to see how long it takes for prostate cancer to come back in patients who have had surgery to remove their prostate gland (radical prostatectomy)…NCT01927627·Cleveland, Ohio

PreviousPage 2 of 14Next

Other Conditions in Cleveland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma